EFFECTS OF TREATMENT WITH SIMVASTATIN AND PRAVASTATIN ON COGNITIVE FUNCTION IN PATIENTS WITH HYPERCHOLESTEROLEMIA

被引：41
|
作者：
CUTLER, N
SRAMEK, J
VEROFF, A
BLOCK, G
STAUFFER, L
LINES, C
机构：
[1] CALIF CLIN TRIALS,BEVERLY HILLS,CA 90211
[2] MERCK SHARP & DOHME LTD,RES LABS,BLUE BELL,PA 19422
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1995年 / 39卷 / 03期
关键词：
SIMVASTATIN; PRAVASTATIN; CHOLESTEROL; COGNITIVE FUNCTION;
D O I：
10.1111/j.1365-2125.1995.tb04458.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The effects of equi-efficacious doses of the cholesterol-lowering drugs simvastatin (20 mg day(-1)) and pravastatin (40 mg day(-1)) on tests of cognitive function were investigated in a double-blind, placebo-controlled, 2-period (4 weeks per period), incomplete block, crossover study of 36 patients (24 per treatment) with hypercholesterolaemia. After 4 weeks neither of the active treatments differed significantly from placebo on any cognitive measure.
引用
收藏
页码：333 / 336
页数：4
相关论文
共 50 条
  • [31] Effects of simvastatin therapy on circulating adipocytokines in patients with hypercholesterolemia
    Koh, Kwang Kon
    Quon, Michael J.
    Sakuma, Ichiro
    Lee, Yonghee
    Lim, Soo
    Han, Seung Hwan
    Shin, Eak Kyun
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 146 (03) : 434 - 437
  • [32] Effects of pravastatin on carotid plaques and preventing stroke in patients with hypercholesterolemia
    Zeng, XH
    Zeng, XJ
    Li, YY
    Zeng, YH
    STROKE, 2004, 35 (01) : 257 - 257
  • [33] EFFECTS OF CHRONIC TREATMENT WITH PRAVASTATIN IN PATIENTS WITH MILD HYPERCHOLESTEROLEMIA AND ASSOCIATED CARDIOVASCULAR RISK-FACTORS
    FOGARI, R
    TETTAMANTI, F
    ZOPPI, A
    MALAMANI, GD
    LAZZARI, P
    AGOSTA, G
    MAGNI, A
    CORRADI, L
    CASINI, A
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1992, 51 (06): : 896 - 905
  • [34] PRAVASTATIN - A NEW DRUG FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA
    JUNGNICKEL, PW
    CANTRAL, KA
    MALOLEY, PA
    CLINICAL PHARMACY, 1992, 11 (08): : 677 - 689
  • [35] Effects of pravastatin treatment on lipoprotein levels and composition in patients with type 2 diabetes mellitus and hypercholesterolemia
    Miccoli, R
    Giovannitti, MG
    Ceraudo, A
    Anichini, R
    Dolci, A
    Trifirò, R
    Navalesi, R
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2000, 61 (02): : 107 - 118
  • [36] EFFECTS OF PRAVASTATIN AND CHOLESTYRAMINE IN PRIMARY HYPERCHOLESTEROLEMIA
    BARD, JM
    PARRA, HJ
    DOUSTEBLAZY, P
    FRUCHART, JC
    NEW ADVANCES IN THE CONTROL OF LIPID METABOLISM : FOCUS ON PRAVASTATIN, 1989, 162 : 29 - 34
  • [37] Effects of lovastatin and pravastatin on cognitive function in military aircrew
    Gibellato, MG
    Moore, JL
    Selby, K
    Bower, EA
    AVIATION SPACE AND ENVIRONMENTAL MEDICINE, 2001, 72 (09): : 805 - 812
  • [38] EFFECT OF PRAVASTATIN, CHOLESTYRAMINE OR THEIR COMBINATION IN THE TREATMENT OF HYPERCHOLESTEROLEMIA IN ELDERLY HYPERTENSIVE PATIENTS
    MORGAN, TO
    ANDERSON, A
    MORGAN, O
    BERTRAM, D
    PIGEON, A
    RENNIE, G
    JOUGHIN, J
    CLINICAL DRUG INVESTIGATION, 1995, 9 (06) : 314 - 323
  • [39] Simvastatin and pravastatin equally improve flow-mediated dilation in males with hypercholesterolemia
    Sebestjen, M
    Boh, M
    Keber, I
    WIENER KLINISCHE WOCHENSCHRIFT, 2002, 114 (23-24) : 999 - 1003
  • [40] Treatment of patients with homozygous familial hypercholesterolemia with expanded doses of simvastatin
    Raal, FJ
    Pilcher, GJ
    Pieterse, AC
    Stein, EA
    Laskarzewski, P
    Illingworth, DR
    Melino, MR
    Mitchel, YB
    ATHEROSCLEROSIS, 1997, 130 : 119 - 119
12345